Viatris logo

Viatris Stock

StockStock
ISIN: US92556V1061
Ticker: VTRS
US92556V1061
VTRS

Price

Historical dividends and forecast

All dividend data

Viatris has so far distributed $0.36 in 2024. The next dividend will be paid on 13.12.2024


$0.163

CHART BY

Frequently asked questions

What is Viatris's market capitalization?

The market capitalization of Viatris is $15.52B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Viatris?

Viatris's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.739. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Viatris's stock?

Currently, 8 analysts cover Viatris's stock, with a consensus target price of $12.33. Analyst ratings provide insights into the stock's expected performance.

What is Viatris's revenue over the trailing twelve months?

Over the trailing twelve months, Viatris reported a revenue of $15.05B.

Is Viatris paying dividends?

Yes, Viatris is paying dividends. The next payment is scheduled for 13.12.2024, with an expected amount of .

What is the EBITDA for Viatris?

Viatris's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $4.14B. EBITDA measures the company's overall financial performance.

What is the free cash flow of Viatris?

Viatris has a free cash flow of $1.32B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Viatris's stock?

The 5-year beta for Viatris is 0.95. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Viatris have, and what sector and industry does it belong to?

Viatris employs approximately 38,000 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Viatris's shares?

The free float of Viatris is 1.19B. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 
$15.52B

5Y beta

 
0.95

EPS (TTM)

 
-$0.739

Free Float

 
1.19B

Revenue (TTM)

 
$15.05B

EBITDA (TTM)

 
$4.14B

Free Cashflow (TTM)

 
$1.32B

Pricing

1D span
$12.59$13.08
52W span
$9.08$13.62

Analyst Ratings

The price target is $12.33 and the stock is covered by 8 analysts.

Buy

1

Hold

5

Sell

2

Information

Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s ARV franchise. The Company’s portfolio comprises approved molecules across a range of key therapeutic areas, including globally recognized iconic and key brands and generics, including complex products. The Company operates manufacturing sites across worldwide that produce oral solid doses, injectables and complex dosage forms.

38,000

Biotechnology & Drugs

Health Care

Identifier

ISIN

US92556V1061

Primary Ticker

VTRS

Knockouts

Join the conversation